Molecular Characteristics and Responses to EGFR/em> Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer Patients with EGFR Exon 19 Insertions

0
16
Next-generation sequencing was performed to profile the molecular characteristics of 83 NSCLC patients with EGFR 19ins.
[BMC Medicine]
Full Article